Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Is Belumosudil Effective?The efficacy of belumosudil has been validated in two clinical studies involving a total of 186 patients with chronic graft-versus-host disease (GVHD). In ···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：212
Dosage and Missed Dose Administration of BelumosudilBelumosudil tablets should be swallowed whole with a full glass of water. Under no circumstances should they be split, crushed, ···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：251
Unique Immune Modulating Mechanism of BelumosudilChronic GVHD is characterized by severe immune system imbalance. Following hematopoietic stem cell transplantation, donor immune ce···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：203
Common Side Effects of BelumosudilIn clinical studies, some common side effects were reported in patients taking belumosudil. These included infections, fatigue or weakness, nausea···【more】
Article source：Captain MedicineRelease date：2026-04-02Recommended：214
While effectively inhibiting tumor growth, erlotinib may also cause a range of side effects. These adverse reactions vary from person to person. Most patients may experience mild t···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：250
Erlotinib is a targeted therapeutic agent directed against specific gene mutations, primarily indicated for the treatment of non-small cell lung cancer and advanced pancreatic canc···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：190
Ponatinib is a potent tyrosine kinase inhibitor indicated primarily for the treatment of chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL), esp···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：230
Ponatinib is a prescription medication. Patients must not adjust their dosage or discontinue treatment on their own. All dosage modifications should be made under close supervision···【more】
Article source：Captain MedicineRelease date：2026-04-01Recommended：197
All medications may be associated with certain adverse reactions, and asciminib is no exception. Most reactions are mild to moderate and manageable, but severe adverse events requi···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：235
The recommended dosage of asciminib should be determined through comprehensive evaluation based on factors including the patient's disease phase (e.g., chronic phase or acceler···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：186
Awareness of these potential side effects helps patients identify them early and take timely intervention measures. However, it should be noted that the assessment and management o···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：189
As a targeted therapeutic agent, the dosage and administration of afatinib should be individually adjusted based on the patient’s specific condition, body surface area and tolerabi···【more】
Article source：Captain MedicineRelease date：2026-03-31Recommended：218
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
